June 11, 2024
Congressional Hearing Focuses on Key Issues Facing FDA and the Future of Cancer Research
Testimony for the hearing noted the recent authorities provided through the Food and Drug Omnibus Reform Act of 2022 (FDORA) designed to enhance the accelerated approval program and ensure timely generation of confirmatory evidence.
Read More